tiprankstipranks
Trending News
More News >
Ironwood backs FY25 revenue view $260M-$290M, consensus $287.07M
PremiumThe FlyIronwood backs FY25 revenue view $260M-$290M, consensus $287.07M
16d ago
Ironwood downgraded to Hold from Buy at Craig-Hallum
Premium
The Fly
Ironwood downgraded to Hold from Buy at Craig-Hallum
25d ago
Ironwood Pharma: Hold Rating Amid Uncertainty Over Apraglutide’s Phase 3 Trial and Strategic Options
Premium
Ratings
Ironwood Pharma: Hold Rating Amid Uncertainty Over Apraglutide’s Phase 3 Trial and Strategic Options
26d ago
Ironwood price target lowered to $1 from $3 at Leerink
PremiumThe FlyIronwood price target lowered to $1 from $3 at Leerink
27d ago
Citizens JMP downgrades Ironwood on delayed apraglutide launch
Premium
The Fly
Citizens JMP downgrades Ironwood on delayed apraglutide launch
27d ago
Ironwood downgraded to Market Perform from Outperform at Citizens JMP
Premium
The Fly
Ironwood downgraded to Market Perform from Outperform at Citizens JMP
27d ago
Ironwood receives Nasdaq non-compliance notification
PremiumThe FlyIronwood receives Nasdaq non-compliance notification
1M ago
Ironwood Pharma Delays 10-K Filing Due to Internal Issues
Premium
Company Announcements
Ironwood Pharma Delays 10-K Filing Due to Internal Issues
2M ago
Strategic Developments and NDA Enhancements Drive Buy Rating for Ironwood Pharma
Premium
Ratings
Strategic Developments and NDA Enhancements Drive Buy Rating for Ironwood Pharma
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100